Quotes 5-day view Delayed Nasdaq
05/15/2013
05/16/2013
05/17/2013
05/20/2013
05/21/2013
Date
129.63(c)
123.48(c)
124.91(c)
123.12(c)
123.5 Last
2 432 370
4 953 617
4 122 228
2 243 366
2 401 866 Volume
-0.41% -4.74% +1.16% -1.43% +0.31% Change
Celgene Corporation specializes in the design, development, and sale of products for treating cancer and immune system disorders. Net sales break down by product family as follows:
- therapeutic products (99.7%);
- other (0.3%): cellular therapy products and biological materials for implants, for...
Surperformance© rating of Celgene Corporation
Trading Rating : Investor Rating :
Chart CELGENE CORPORATION
Duration :
Auto.
2 month
3 month
6 month
9 month
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Sales 2013
6 151 M
EBIT 2013
2 963 M
Net income 2013
2 026 M
Finance 2013
2 048 M
Yield 2013
-
Sales 2014
7 042 M
EBIT 2014
3 516 M
Net income 2014
2 416 M
Finance 2014
4 788 M
Yield 2014
-
PER 2013
26,38
PER 2014
21,21
EV / Sales 2013
8,02x
EV / Sales 2014
6,61x
Capitalization
51 356 M
Latest news on CELGENE CORPORATION
10h ago CELGENE CORPORATION : Today’s Research on CELG, ARNA, INCY, SPPI, and GERN05/06 CELGENE CORPORATION : Apremilast Achieves Statistical Significance for the Prima..04/29 CELGENE CORPORATION : to Webcast at Upcoming Investor Conferences and Analyst Da..04/26 DJ As Biotechnology Stocks Soar, Bubble Talk Percolates 04/26 EU body backs new Roche, Astellas, Sanofi, Vivus drugs 04/25 DJ CELGENE CORPORATION : Celgene Profit Falls, Hurt by Increased Costs for Drug Lau..04/25 DJ CELGENE CORPORATION : Celgene 1st-Quarter Net Down 4.1% Amid Increased Costs04/25 CELGENE CORPORATION : Celgene Reports First Quarter 2013 Operating and Financial..04/04 DJ Cyclacel Agrees to Sell Patents to Celgene; Litigation to Be Dismissed 04/03 CELGENE CORPORATION : to Announce First Quarter 2013 Results on April 25, 201303/15 DJ ONYX PHARMACEUTICALS CEO : Seeking Acquisition Targets03/15 DJ ONYX PHARMACEUTICALS CEO : Seeking Acquisition Targets
Forum CELGENE CORPORATION
Technical analysis trends
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
